Treace Medical Concepts Stock (NASDAQ: TMCI) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 399.412K |
Day Range | - - - |
52 Wk Range | 5.270 - 27.700 |
Market Cap | $660.857M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 5.47% |
Days to Cover | 6.56 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Treace Medical Concepts (NASDAQ: TMCI) through any online brokerage.
Other companies in Treace Medical Concepts’s space includes: NeuroPace (NASDAQ:NPCE), SI-BONE (NASDAQ:SIBN), Varex Imaging (NASDAQ:VREX), Fractyl Health (NASDAQ:GUTS) and Inari Medical (NASDAQ:NARI).
The latest price target for Treace Medical Concepts (NASDAQ: TMCI) was reported by Truist Securities on Friday, December 22, 2023. The analyst firm set a price target for 16.00 expecting TMCI to rise to within 12 months (a possible 49.95% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Treace Medical Concepts (NASDAQ: TMCI) is $10.67 last updated April 24, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Treace Medical Concepts.
Treace Medical Concepts’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Treace Medical Concepts.
Treace Medical Concepts is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.